Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards

Life Health > Health Insurance > Life Insurance Strategies

Firm Develops Formulary Benchmark

Your article was successfully shared with the contacts you provided.

Researchers at Towers Perrin Inc. have developed a system that employers can use to analyze the quality and cost efficiency of their prescription plan drug lists.

The new Towers Perrin Reference Formulary System is unusual because it was developed by an independent consulting firm, not by a pharmacy benefit manager that might have a financial stake in encouraging employers to cover certain brand-name drugs rather than others, according to Towers Perrin, Stamford, Conn.

The benchmark formulary does not take rebates or other discounts into effect, and it does include brand-name products that are especially useful, Towers Perrin says.

Towers Perrin developed the reference formulary system by drawing on data from the Towers Perrin Rx Collaborative, an employer drug purchasing coalition it has established.


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.